$56.05 -$1.15 (0.0%)

04:00 PM EDT on 07/16/19

Genomic Health, Inc. (NASDAQ:GHDX)

CAPS Rating: 5 out of 5

A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

Current Price $56.05 Mkt Cap $2.1B
Open $57.46 P/E Ratio 0.00
Prev. Close $56.05 Div. (Yield) $0.00 (0.0%)
Daily Range $55.10 - $57.46 Volume 104,293
52-Wk Range $50.85 - $86.70 Avg. Daily Vol. 11

Caps

How do you think NASDAQ:GHDX will perform against the market?

Add Stock to CAPS Watchlist

All Players

325 Outperform
19 Underperform
 

All-Star Players

88 Outperform
6 Underperform
 

Wall Street

12 Outperform
2 Underperform
 

Top NASDAQ:GHDX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

FoolishDane (< 20)
Submitted November 20, 2012

A single treatment won't work for everyone, so there's definite promise in a company working to perfect tests so that individualized treatments may be prescribed. This would result in less frustration for the patient and his/her family and,… More

Dormin111ob (98.23)
Submitted July 14, 2010

Losing money. Long slide downward.

NASDAQ:GHDX VS S&P 500 (SPY)

Fools bullish on NASDAQ:GHDX are also bullish on:

Fools bearish on NASDAQ:GHDX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GHDX.

Recs

0
Member Avatar TMFBlacknGold (92.71) Submitted: 10/17/2018 11:25:30 AM : Outperform Start Price: $62.13 NASDAQ:GHDX Score: -17.96

Genomic Health is growing year-over-year revenue at a healthy clip every quarter and is finally profitable. That's a really nice combination for long-term investors looking to get into an important new area of medicine. Invitae is growing revenue faster, but still losing a lot of money (it hopes to replicate Genomic Health's success in the coming years). Myriad Genetics delivers higher levels of profits, but has struggled to replace revenue lost from the legacy business (although the acquisition in summer 2018 should help).

Recs

0
Member Avatar Horsemonkey (63.57) Submitted: 8/1/2018 12:11:03 AM : Outperform Start Price: $53.36 NASDAQ:GHDX Score: -1.41

Genomic Health makes cancer tests. The CEO Kim Popovits is well liked and respected. The company is selling more tests for different types and stages of cancer, and its revenue prospects continue to grow. This a small cap company at 1.8 billion so the growth story is just getting started for Genomic Health.

Recs

0
Member Avatar MaestroFool (88.13) Submitted: 6/14/2017 7:07:02 PM : Outperform Start Price: $28.13 NASDAQ:GHDX Score: +55.53

Genomics and personalized medicine are the future. Outperform for the next 5+ years.

Leaderboard

Find the members with the highest scoring picks in GHDX.

Score Leader

songjon101

songjon101 (63.68) Score: +462.73

The Score Leader is the player with the highest score across all their picks in GHDX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ezMarty < 20 9/6/2006 Outperform 5Y $11.84 +373.40% +145.39% +228.00 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. dkelleher83 38.25 9/18/2006 Outperform 5Y $13.44 +317.04% +141.27% +175.77 4 Comments
mebrownj 65.15 7/22/2010 Outperform 5Y $12.41 +351.65% +176.66% +175.00 0 Comment
o556 95.21 7/19/2010 Outperform 1Y $12.32 +354.95% +179.99% +174.96 0 Comment
MickeyJerry < 20 10/9/2006 Outperform 1Y $13.77 +307.04% +135.91% +171.14 1 Comment
Frannah < 20 9/20/2006 Outperform 3M $13.68 +309.72% +139.06% +170.66 0 Comment
tamvanta66 77.85 9/15/2006 Outperform 3Y $13.80 +306.16% +139.86% +166.29 0 Comment
mattchesky 54.64 7/13/2010 Outperform 5Y $12.76 +339.26% +174.38% +164.89 0 Comment
genericstockguy 39.69 9/14/2006 Outperform 3Y $13.81 +305.87% +142.44% +163.43 1 Comment
ekrupnik < 20 10/5/2006 Outperform 3Y $14.06 +298.65% +135.84% +162.81 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCanaccord 62.55 1/6/2016 Outperform NS $35.00 +60.14% +51.12% +9.02 0 Comment
TrackGoldmanSach 80.92 6/26/2013 Underperform NS $31.57 +77.54% +87.48% +9.94 0 Comment
TrackCreditSuiss 88.05 9/26/2012 Outperform NS $35.53 +57.75% +108.05% -50.30 0 Comment
TrackZacks < 20 7/6/2012 Outperform 3M $36.24 -22.82% +1.97% -24.79 11/9/2012 @ $27.97 1 Comment
TrackUltraLong < 20 5/21/2012 Underperform NS $32.30 +73.53% +128.50% +54.98 1 Comment
TrackZacks < 20 1/23/2012 Outperform 3M $26.85 +7.90% +2.24% +5.65 2/15/2012 @ $28.97 1 Comment
TrackZacks < 20 11/3/2011 Outperform 3M $25.11 +9.68% +2.28% +7.40 1/11/2012 @ $27.54 1 Comment
TrackLadenburg < 20 11/2/2011 Outperform NS $23.97 +133.83% +142.05% -8.22 0 Comment
TrackSwensen < 20 12/31/2010 Outperform NS $21.39 +162.04% +139.38% +22.66 0 Comment
TrackZacks < 20 11/16/2010 Outperform 3M $17.50 +30.51% +5.20% +25.32 12/17/2010 @ $22.84 1 Comment
TrackZacks < 20 8/5/2010 Underperform 3M $14.00 +29.07% +7.76% -21.31 11/9/2010 @ $18.07 1 Comment
trackthinkequity 91.34 1/8/2010 Outperform NS $18.01 +211.22% +162.97% +48.25 0 Comment
TrackZacks < 20 11/6/2009 Underperform 3M $20.08 -2.99% +7.77% +10.75 3/11/2010 @ $19.48 1 Comment
TrackTWeisel 87.37 6/11/2009 Outperform NS $18.27 +206.79% +220.22% -13.43 0 Comment
TrackMichaelBrus 87.05 2/14/2008 Outperform 1Y $23.34 +140.15% +131.09% +9.05 0 Comment
TrackRBCCapMkts 83.73 2/7/2008 Outperform NS $23.64 +137.10% +137.00% +0.09 0 Comment
TrackCantorFitz 39.57 2/6/2008 Outperform NS $23.14 +142.22% +132.10% +10.12 0 Comment
TrackCanaccord 62.55 1/29/2008 Outperform NS $22.17 -1.10% -6.78% +5.68 9/8/2008 @ $21.93 0 Comment
TrackLeerinkSwan 97.27 5/31/2007 Outperform NS $17.87 +39.12% -11.14% +50.26 1/17/2008 @ $24.86 0 Comment
TrackPiperJaff 86.20 3/27/2007 Outperform NS $17.91 +212.95% +121.41% +91.55 0 Comment
TrackRBCCapMkts 83.73 3/7/2007 Underperform NS $18.98 +19.81% +5.59% -14.22 12/21/2007 @ $22.74 0 Comment
TrackJimCramer 86.28 11/21/2006 Outperform 3W $16.35 +242.81% +126.07% +116.74 0 Comment
TrackCantorFitz 39.57 11/7/2006 Outperform NS $16.66 +46.52% +10.42% +36.10 11/1/2007 @ $24.41 0 Comment
TrackJMP 84.15 11/6/2006 Outperform NS $15.38 +264.43% +132.27% +132.16 0 Comment

Advertisement